NASDAQ · Biotechnology
Gilead Sciences, Inc. (GILD)
Gilead develops antiviral, oncology and inflammatory-disease medicines and has a large HIV treatment franchise. Founded in 1987 and headquartered in Foster City, California, Gilead Sciences, Inc. employs approximately 18,000 people.
Reference price$249.85
Daily change-0.83%
Market cap$475B
P/E ratio—
Analyst consensusPending market sync
Price target$272.34
Next earningsPending market sync
Dividend yield2.45%
Company profile
Headquarters
Founded
1987
Employees
18,000
Related coverage